{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:40:15Z","timestamp":1788381615866,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T00:00:00Z","timestamp":1532736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40291-018-0353-9","type":"journal-article","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T03:12:07Z","timestamp":1532747527000},"page":"613-619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction"],"prefix":"10.1007","volume":"22","author":[{"given":"Danila","family":"Morano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lapucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carla","family":"Pittalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-1810","authenticated-orcid":false,"given":"Antonio","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,28]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/01.AOG.0000423819.85283.f4","volume":"120","author":"American College of Obstetricians and Gynecologists Committee on Genetics","year":"2012","unstructured":"American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012;120:1532\u20134.","journal-title":"Obstet Gynecol"},{"key":"353_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","volume":"48","author":"YY Lui","year":"2002","unstructured":"Lui YY, Chik KW, Chiu RWK, Ho CY, Lam CW, Lo YMD. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem. 2002;48:421\u20137.","journal-title":"Clin Chem"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/pd.1700","volume":"27","author":"M Alberry","year":"2007","unstructured":"Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, Soothill PW. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27:415\u20138.","journal-title":"Prenat Diagn"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/uog.14694","volume":"45","author":"D Wright","year":"2015","unstructured":"Wright D, Wright A, Nicolaides KH. A unified approach to risk assessment for fetal aneuploidies. Ultrasound Obstet Gynecol. 2015;45:48\u201354.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bpobgyn.2016.10.006","volume":"38","author":"F Figueras","year":"2017","unstructured":"Figueras F, Gratacos E. An integrated approach to fetal growth restriction. Best Pract Res Clin Obstet Gynaecol. 2017;38:48\u201358.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/uog.15884","volume":"48","author":"SJ Gordijn","year":"2016","unstructured":"Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48:333\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bpobgyn.2018.02.009","volume":"49","author":"AA Baschat","year":"2018","unstructured":"Baschat AA. Planning management and delivery of the growth-restricted fetus. Best Pract Res Clin Obstet Gynaecol. 2018;49:53\u201365.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"R2","key":"353_CR8","doi-asserted-by":"publisher","first-page":"R237","DOI":"10.1093\/hmg\/ddx210","volume":"26","author":"I Manokhina","year":"2017","unstructured":"Manokhina I, Del Gobbo GF, Konwar C, Wilson SL, Robinson WP. Review: placental biomarkers for assessing fetal health. Hum Mol Genet. 2017;26(R2):R237\u201345.","journal-title":"Hum Mol Genet"},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/uog.14904","volume":"46","author":"LC Poon","year":"2015","unstructured":"Poon LC, Lesmes C, Gallo DM, Akolekar R, Nicolaides KH. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19\u201324\u00a0weeks. Ultrasound Obstet Gynecol. 2015;46:437\u201345.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"353_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/uog.15879","volume":"48","author":"F Crovetto","year":"2016","unstructured":"Crovetto F, Triunfo S, Crispi F, Rodriguez-Sureda V, Roma E, Dominguez C, Gratacos E, Figueras F. First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction. Ultrasound Obstet Gynecol. 2016;48:340\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40291-016-0245-9","volume":"21","author":"E Contro","year":"2017","unstructured":"Contro E, Bernabini D, Farina A. Cell-free fetal DNA for the prediction of pre-eclampsia at the first and second trimesters: a systematic review and meta-analysis. Mol Diagn Ther. 2017;21:125\u201335.","journal-title":"Mol Diagn Ther"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/pd.973","volume":"24","author":"A Farina","year":"2004","unstructured":"Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. Total cellfree DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn. 2004;24:722\u20136.","journal-title":"Prenat Diagn"},{"key":"353_CR13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/clinchem\/45.2.184","volume":"45","author":"YM Lo","year":"1999","unstructured":"Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999;45:184\u20138.","journal-title":"Clin Chem"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000444524","volume":"40","author":"SY Kim","year":"2016","unstructured":"Kim SY, Kim HJ, Park SY, Han YJ, Choi JS, Ryu HM. Early prediction of hypertensive disorders of pregnancy using cell-free fetal DNA, cell-free total DNA, and biochemical markers. Fetal Diagn Ther. 2016;40:255\u201362.","journal-title":"Fetal Diagn Ther"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/pd.1504","volume":"26","author":"M Smid","year":"2006","unstructured":"Smid M, Galbiati S, Lojacono A, Valsecchi L, Platto C, Cavoretto P, Calza S, Ferrari A, Ferrari M, Cremonesi L. Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies. Prenat Diagn. 2006;26:785\u201390.","journal-title":"Prenat Diagn"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/uog.14671","volume":"45","author":"DL Rolnik","year":"2015","unstructured":"Rolnik DL, O\u2019Gorman N, Fiolna M, van den Boom D, Nicolaides KH, Poon LC. Maternal plasma cell-free DNA in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2015;45:106\u201311.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/AOG.0000000000002728","volume":"132","author":"P Benn","year":"2018","unstructured":"Benn P, Valenti E, Shah S, Martin K, Demko Z. Factors associated with informative redraw after an initial no result in noninvasive prenatal testing. Obstet Gynecol. 2018;132:428\u201335.","journal-title":"Obstet Gynecol"},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6","volume":"16","author":"LM Neveux","year":"1996","unstructured":"Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn. 1996;16:1115\u20139.","journal-title":"Prenat Diagn"},{"key":"353_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18993","author":"DL Rolnik","year":"2018","unstructured":"Rolnik DL, da Silva Costa F, Lee TJ, Schmid M, McLennan AC. Association between fetal fraction on cell-free DNA testing and first trimester markers for pre-eclampsia. Ultrasound Obstet Gynecol. 2018. https:\/\/doi.org\/10.1002\/uog.18993 .","journal-title":"Ultrasound Obstet Gynecol"},{"key":"353_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/pd.788","volume":"24","author":"A Farina","year":"2004","unstructured":"Farina A, Sekizawa A, Sugito Y, Iwasaki M, Jimbo M, Saito H, Okai T. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn. 2004;24:83\u20136.","journal-title":"Prenat Diagn"},{"key":"353_CR21","doi-asserted-by":"crossref","unstructured":"Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah SA, Avent ND, Soothill PW. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol. 2009;200:98.e1\u20136.","DOI":"10.1016\/j.ajog.2008.07.063"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/pd.2372","volume":"29","author":"S Illanes","year":"2009","unstructured":"Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, Arraztoa JA, Michea L, Soothill PW. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn. 2009;29:1118\u201322.","journal-title":"Prenat Diagn"},{"key":"353_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/10641955.2017.1385794","volume":"36","author":"S Eche","year":"2017","unstructured":"Eche S, Mackraj I, Moodley J. Circulating fetal and total cell-free DNA, and sHLA-G in black South African women with gestational hypertension and pre-eclampsia. Hypertens Pregnancy. 2017;36:295\u2013301.","journal-title":"Hypertens Pregnancy."},{"key":"353_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s11906-013-0395-7","volume":"15","author":"D Tannetta","year":"2013","unstructured":"Tannetta D, Sargent I. Placental disease and the maternal syndrome of preeclampsia: missing links? Curr Hypertens Rep. 2013;15:590\u20139.","journal-title":"Curr Hypertens Rep"},{"key":"353_CR25","doi-asserted-by":"crossref","unstructured":"Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH, Lo YM. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem. 2002;48:2141.","DOI":"10.1093\/clinchem\/48.12.2141"},{"key":"353_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/humrep\/15.1.218","volume":"15","author":"R Al-Mufti","year":"2000","unstructured":"Al-Mufti R, Lees C, Albaiges G, Hambley H, Nicolaides KH. Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod. 2000;15:218\u201321.","journal-title":"Hum Reprod"},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ajh\/hpx024","volume":"30","author":"R Mu\u00f1oz-Hern\u00e1ndez","year":"2017","unstructured":"Mu\u00f1oz-Hern\u00e1ndez R, Medrano-Campillo P, Miranda ML, Macher HC, Praena-Fern\u00e1ndez JM, Vallejo-Vaz AJ, Dominguez-Simeon MJ, Moreno-Luna R, Stiefel P. Total and fetal circulating cell-free DNA, angiogenic, and antiangiogenic factors in preeclampsia and HELLP syndrome. Am J Hypertens. 2017;30:673\u201382.","journal-title":"Am J Hypertens"},{"key":"353_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/pd.965","volume":"24","author":"A Sekizawa","year":"2004","unstructured":"Sekizawa A, Farina A, Koide K, Iwasaki M, Honma S, Ichizuka K, Saito H, Okai T. beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. Prenat Diagn. 2004;24:697\u2013700.","journal-title":"Prenat Diagn"},{"key":"353_CR29","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1093\/humrep\/dem154","volume":"22","author":"CJ Jorgez","year":"2007","unstructured":"Jorgez CJ, Dang DD, Wapner R, Farina A, Simpson JL, Bischoff FZ. Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21. Hum Reprod. 2007;22:2267\u201372.","journal-title":"Hum Reprod"},{"key":"353_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00439-002-0853-9","volume":"112","author":"T Wataganara","year":"2003","unstructured":"Wataganara T, LeShane ES, Farina A, Messerlian GM, Lee T, Canick JA, Bianchi DW. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy. Hum Genet. 2003;112:204\u20138.","journal-title":"Hum Genet"},{"key":"353_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejogrb.2018.03.048","volume":"224","author":"N Suzumori","year":"2018","unstructured":"Suzumori N, Sekizawa A, Ebara T, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Izumi H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Okai T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Shirato N, Yotsumoto J, Nishiyama M, Hirose T, Sago H. Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2018;224:165\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"353_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/AOG.0000000000000345","volume":"124","author":"EL Duryea","year":"2014","unstructured":"Duryea EL, Hawkins JS, McIntire DD, Casey BM, Leveno KJ. A revised birth weight reference for the United States. Obstet Gynecol. 2014;124:16.","journal-title":"Obstet Gynecol"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-018-0353-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-018-0353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-018-0353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T17:40:22Z","timestamp":1604684422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-018-0353-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,28]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s40291-018-0353-9","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,28]]},"assertion":[{"value":"28 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"D. Morano, S. Rossi, M.C. Pittalis, C. Lapucci, and A. Farina have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not receive any funding.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}